Several large investigations have demonstrated the considerable efficacy of TDF/FTC taken daily or intermittently, reducing the risk of HIV acquisition by more than 95% in high-risk individuals.
Jason J. Schafer, PharmD, MPH, BCPS AQ-ID, AAHIVP
Advertisement
Articles by Jason J. Schafer, PharmD, MPH, BCPS AQ-ID, AAHIVP
Advertisement
Latest Updated Articles
Studies Demonstrate the Power of PrEPPublished: November 5th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
2
From Stigma to Breakthrough: Psychedelic Medicine
3
Pharmacists Can Drive Equitable Diagnostics Access, Improve Antimicrobial Resistance Stewardship
4
CHEST 2025: Improving Access to Chronic Cough Treatment Through a Digital Therapeutic Solution
5
